世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Travelers Vaccines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Travelers Vaccines was estimated to be worth US$ 4291 million in 2025 and is projected to reach US$ 7682 million, growing at a CAGR of 8.8% from 2026 to 2032. The potential s... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Travelers Vaccines was estimated to be worth US$ 4291 million in 2025 and is projected to reach US$ 7682 million, growing at a CAGR of 8.8% from 2026 to 2032.The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Travelers Vaccines cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations. A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation. In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc. Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%. This report provides a comprehensive view of the global market for Travelers Vaccines, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by End Users. The Travelers Vaccines market size, estimations, and forecasts are presented in terms of sales volume (K Doses) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Travelers Vaccines. Market Segmentation By Company GlaxoSmithKline Sanofi Pasteur Merck Pfizer CNBG Sanofi Pasteur MSD Serum Institute of India Biokangtai Segment by Type Meningococcal Vaccine Japanese Encephalitis Vaccine Yellow Fever Vaccine Hepatitis Vaccine Cholera Vaccine Other Segment by End Users Tourists Students Workers Others By Region North America Europe China Japan Consumption by Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications. Chapter 2: Provides a detailed analysis of the Travelers Vaccines manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A). Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities. Chapter 4: Analyzes market segmentation by End Users, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities. Chapter 5: Presents Travelers Vaccines sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide. Chapter 6: Presents Travelers Vaccines sales and revenue at the country level. It provides segmented data by Type and by End Users for each country/region. Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc. Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Travelers Vaccines Product Introduction 1.2 Global Travelers Vaccines Market Size Forecast 1.2.1 Global Travelers Vaccines Sales Value (2021–2032) 1.2.2 Global Travelers Vaccines Sales Volume (2021–2032) 1.2.3 Global Travelers Vaccines Sales Price (2021–2032) 1.3 Travelers Vaccines Market Trends & Drivers 1.3.1 Travelers Vaccines Industry Trends 1.3.2 Travelers Vaccines Market Drivers & Opportunities 1.3.3 Travelers Vaccines Market Challenges 1.3.4 Travelers Vaccines Market Restraints 1.3.5 Impact of U.S. Tariffs 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Travelers Vaccines Players Revenue Ranking (2025) 2.2 Global Travelers Vaccines Revenue by Company (2021–2026) 2.3 Global Travelers Vaccines Sales Volume Ranking of Players (2025) 2.4 Global Travelers Vaccines Sales Volume by Company (2021–2026) 2.5 Global Travelers Vaccines Average Price by Company (2021–2026) 2.6 Key Manufacturers Travelers Vaccines Manufacturing Base and Headquarters 2.7 Key Manufacturers Travelers Vaccines Product Offerings 2.8 Key Manufacturers Start of Mass Production of Travelers Vaccines 2.9 Travelers Vaccines Market Competitive Analysis 2.9.1 Travelers Vaccines Market Concentration Rate (2021–2026) 2.9.2 Global 5 and 10 Largest Manufacturers by Travelers Vaccines Revenue in 2025 2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Travelers Vaccines revenue, 2025 2.10 Mergers & Acquisitions and Expansion 3 Segmentation Travelers Vaccines Market Classification 3.1 Introduction by Type 3.1.1 Meningococcal Vaccine 3.1.2 Japanese Encephalitis Vaccine 3.1.3 Yellow Fever Vaccine 3.1.4 Hepatitis Vaccine 3.1.5 Cholera Vaccine 3.1.6 Other 3.1.7 Global Travelers Vaccines Sales Value by Type 3.1.7.1 Global Travelers Vaccines Sales Value by Type (2021 vs 2025 vs 2032) 3.1.7.2 Global Travelers Vaccines Sales Value, by Type (2021–2032) 3.1.7.3 Global Travelers Vaccines Sales Value, by Type (%), 2021–2032 3.1.8 Global Travelers Vaccines Sales Volume by Type 3.1.8.1 Global Travelers Vaccines Sales Volume by Type (2021 vs 2025 vs 2032) 3.1.8.2 Global Travelers Vaccines Sales Volume, by Type (2021–2032) 3.1.8.3 Global Travelers Vaccines Sales Volume, by Type (%), 2021–2032 3.1.9 Global Travelers Vaccines Average Price by Type (2021–2032) 4 Segmentation by End Users 4.1 Introduction by End Users 4.1.1 Tourists 4.1.2 Students 4.1.3 Workers 4.1.4 Others 4.2 Global Travelers Vaccines Sales Value by End Users 4.2.1 Global Travelers Vaccines Sales Value by End Users (2021 vs 2025 vs 2032) 4.2.2 Global Travelers Vaccines Sales Value, by End Users (2021–2032) 4.2.3 Global Travelers Vaccines Sales Value, by End Users (%), 2021–2032 4.3 Global Travelers Vaccines Sales Volume by End Users 4.3.1 Global Travelers Vaccines Sales Volume by End Users (2021 vs 2025 vs 2032) 4.3.2 Global Travelers Vaccines Sales Volume, by End Users (2021–2032) 4.3.3 Global Travelers Vaccines Sales Volume, by End Users (%), 2021–2032 4.4 Global Travelers Vaccines Average Price by End Users (2021–2032) 5 Segmentation by Region 5.1 Global Travelers Vaccines Sales Value by Region 5.1.1 Global Travelers Vaccines Sales Value by Region: 2021 vs 2025 vs 2032 5.1.2 Global Travelers Vaccines Sales Value by Region (2021–2026) 5.1.3 Global Travelers Vaccines Sales Value by Region (2027–2032) 5.1.4 Global Travelers Vaccines Sales Value by Region (%), 2021–2032 5.2 Global Travelers Vaccines Sales Volume by Region 5.2.1 Global Travelers Vaccines Sales Volume by Region: 2021 vs 2025 vs 2032 5.2.2 Global Travelers Vaccines Sales Volume by Region (2021–2026) 5.2.3 Global Travelers Vaccines Sales Volume by Region (2027–2032) 5.2.4 Global Travelers Vaccines Sales Volume by Region (%), 2021–2032 5.3 Global Travelers Vaccines Average Price by Region (2021–2032) 5.4 North America 5.4.1 North America Travelers Vaccines Sales Value, 2021–2032 5.4.2 North America Travelers Vaccines Sales Value by Country (%), 2025 vs 2032 5.5 Europe 5.5.1 Europe Travelers Vaccines Sales Value, 2021–2032 5.5.2 Europe Travelers Vaccines Sales Value by Country (%), 2025 vs 2032 5.6 Asia Pacific 5.6.1 Asia Pacific Travelers Vaccines Sales Value, 2021–2032 5.6.2 Asia Pacific Travelers Vaccines Sales Value by Region (%), 2025 vs 2032 5.7 South America 5.7.1 South America Travelers Vaccines Sales Value, 2021–2032 5.7.2 South America Travelers Vaccines Sales Value by Country (%), 2025 vs 2032 5.8 Middle East & Africa 5.8.1 Middle East & Africa Travelers Vaccines Sales Value, 2021–2032 5.8.2 Middle East & Africa Travelers Vaccines Sales Value by Country (%), 2025 vs 2032 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Travelers Vaccines Sales Value Growth Trends, 2021 vs 2025 vs 2032 6.2 Key Countries/Regions Travelers Vaccines Sales Value and Sales Volume 6.2.1 Key Countries/Regions Travelers Vaccines Sales Value, 2021–2032 6.2.2 Key Countries/Regions Travelers Vaccines Sales Volume, 2021–2032 6.3 United States 6.3.1 United States Travelers Vaccines Sales Value, 2021–2032 6.3.2 United States Travelers Vaccines Sales Value by Type (%), 2025 vs 2032 6.3.3 United States Travelers Vaccines Sales Value by End Users, 2025 vs 2032 6.4 Europe 6.4.1 Europe Travelers Vaccines Sales Value, 2021–2032 6.4.2 Europe Travelers Vaccines Sales Value by Type (%), 2025 vs 2032 6.4.3 Europe Travelers Vaccines Sales Value by End Users, 2025 vs 2032 6.5 China 6.5.1 China Travelers Vaccines Sales Value, 2021–2032 6.5.2 China Travelers Vaccines Sales Value by Type (%), 2025 vs 2032 6.5.3 China Travelers Vaccines Sales Value by End Users, 2025 vs 2032 6.6 Japan 6.6.1 Japan Travelers Vaccines Sales Value, 2021–2032 6.6.2 Japan Travelers Vaccines Sales Value by Type (%), 2025 vs 2032 6.6.3 Japan Travelers Vaccines Sales Value by End Users, 2025 vs 2032 6.7 South Korea 6.7.1 South Korea Travelers Vaccines Sales Value, 2021–2032 6.7.2 South Korea Travelers Vaccines Sales Value by Type (%), 2025 vs 2032 6.7.3 South Korea Travelers Vaccines Sales Value by End Users, 2025 vs 2032 6.8 Southeast Asia 6.8.1 Southeast Asia Travelers Vaccines Sales Value, 2021–2032 6.8.2 Southeast Asia Travelers Vaccines Sales Value by Type (%), 2025 vs 2032 6.8.3 Southeast Asia Travelers Vaccines Sales Value by End Users, 2025 vs 2032 6.9 India 6.9.1 India Travelers Vaccines Sales Value, 2021–2032 6.9.2 India Travelers Vaccines Sales Value by Type (%), 2025 vs 2032 6.9.3 India Travelers Vaccines Sales Value by End Users, 2025 vs 2032 7 Company Profiles 7.1 GlaxoSmithKline 7.1.1 GlaxoSmithKline Company Information 7.1.2 GlaxoSmithKline Introduction and Business Overview 7.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021–2026) 7.1.4 GlaxoSmithKline Travelers Vaccines Product Offerings 7.1.5 GlaxoSmithKline Recent Developments 7.2 Sanofi Pasteur 7.2.1 Sanofi Pasteur Company Information 7.2.2 Sanofi Pasteur Introduction and Business Overview 7.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021–2026) 7.2.4 Sanofi Pasteur Travelers Vaccines Product Offerings 7.2.5 Sanofi Pasteur Recent Developments 7.3 Merck 7.3.1 Merck Company Information 7.3.2 Merck Introduction and Business Overview 7.3.3 Merck Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021–2026) 7.3.4 Merck Travelers Vaccines Product Offerings 7.3.5 Merck Recent Developments 7.4 Pfizer 7.4.1 Pfizer Company Information 7.4.2 Pfizer Introduction and Business Overview 7.4.3 Pfizer Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021–2026) 7.4.4 Pfizer Travelers Vaccines Product Offerings 7.4.5 Pfizer Recent Developments 7.5 CNBG 7.5.1 CNBG Company Information 7.5.2 CNBG Introduction and Business Overview 7.5.3 CNBG Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021–2026) 7.5.4 CNBG Travelers Vaccines Product Offerings 7.5.5 CNBG Recent Developments 7.6 Sanofi Pasteur MSD 7.6.1 Sanofi Pasteur MSD Company Information 7.6.2 Sanofi Pasteur MSD Introduction and Business Overview 7.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021–2026) 7.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Offerings 7.6.5 Sanofi Pasteur MSD Recent Developments 7.7 Serum Institute of India 7.7.1 Serum Institute of India Company Information 7.7.2 Serum Institute of India Introduction and Business Overview 7.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021–2026) 7.7.4 Serum Institute of India Travelers Vaccines Product Offerings 7.7.5 Serum Institute of India Recent Developments 7.8 Biokangtai 7.8.1 Biokangtai Company Information 7.8.2 Biokangtai Introduction and Business Overview 7.8.3 Biokangtai Travelers Vaccines Sales, Revenue, Price and Gross Margin (2021–2026) 7.8.4 Biokangtai Travelers Vaccines Product Offerings 7.8.5 Biokangtai Recent Developments 8 Industry Chain Analysis 8.1 Travelers Vaccines Industrial Chain 8.2 Travelers Vaccines Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Key Suppliers of Raw Materials 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customer Analysis) 8.5 Sales Model and Sales Channelss 8.5.1 Travelers Vaccines Sales Model 8.5.2 Sales Channels 8.5.3 Travelers Vaccines Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポートQYResearch社の 医薬・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD（vaccines）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
